Apnimed, Inc. Common Stock (APMD) is a publicly traded the market company. As of September 21, 2026, APMD trades at $28.97 with a market cap of $1.21B and a P/E ratio of 0.00. APMD moved +3.24% today. Year to date, APMD is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $16.12 to $35.29. Analyst consensus is strong buy with an average price target of $50.33. Rallies surfaces APMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Apnimed, Inc. Common Stock (APMD) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. APMD moved +3.24% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $28.97 |
| Market Cap | $1.21B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $35.29 |
| 52-Week Low | $16.12 |
| Volume | 471.70K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
4 analysts cover APMD: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $50.33.